HOYA Corp.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3837800006
JPY
23,475.00
-125 (-0.53%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

730.4 k

Shareholding (Mar 2025)

FII

0.06%

Held by 3 FIIs

DII

99.94%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 20.17%

  • Company has very low debt and has enough cash to service the debt requirements
2

The company has declared Positive results for the last 5 consecutive quarters

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 7,095,302 Million (Large Cap)

stock-summary
P/E

28.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.51

stock-summary
Return on Equity

21.73%

stock-summary
Price to Book

7.26

Revenue and Profits:
Net Sales:
220,406 Million
(Quarterly Results - Jun 2025)
Net Profit:
51,401 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
13.3%
0%
13.3%
6 Months
37.89%
0%
37.89%
1 Year
15.16%
0%
15.16%
2 Years
40.61%
0%
40.61%
3 Years
68.95%
0%
68.95%
4 Years
31.29%
0%
31.29%
5 Years
80.92%
0%
80.92%

HOYA Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
8.48%
EBIT Growth (5y)
11.35%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.51
Sales to Capital Employed (avg)
0.82
Tax Ratio
22.43%
Dividend Payout Ratio
27.52%
Pledged Shares
0
Institutional Holding
0.06%
ROCE (avg)
48.78%
ROE (avg)
20.17%
Valuation key factors
Factor
Value
P/E Ratio
28
Industry P/E
Price to Book Value
5.84
EV to EBIT
20.83
EV to EBITDA
17.43
EV to Capital Employed
10.88
EV to Sales
6.00
PEG Ratio
2.57
Dividend Yield
0.00%
ROCE (Latest)
52.24%
ROE (Latest)
21.20%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 3 Foreign Institutions (0.06%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 1.68% vs -1.85% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.68% vs 0.62% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "220,406.00",
          "val2": "216,756.00",
          "chgp": "1.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "78,539.00",
          "val2": "77,191.00",
          "chgp": "1.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "488.00",
          "val2": "427.00",
          "chgp": "14.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,910.00",
          "val2": "-1,380.00",
          "chgp": "-38.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "51,401.00",
          "val2": "51,054.00",
          "chgp": "0.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "299.00%",
          "val2": "297.60%",
          "chgp": "0.14%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 13.56% vs 5.39% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 10.51% vs 8.16% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "866,032.00",
          "val2": "762,610.00",
          "chgp": "13.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "392,211.00",
          "val2": "343,856.00",
          "chgp": "14.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1,326.00",
          "val2": "1,079.00",
          "chgp": "22.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4,733.00",
          "val2": "-7,412.00",
          "chgp": "36.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "201,750.00",
          "val2": "182,566.00",
          "chgp": "10.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "396.80%",
          "val2": "389.00%",
          "chgp": "0.78%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
220,406.00
216,756.00
1.68%
Operating Profit (PBDIT) excl Other Income
78,539.00
77,191.00
1.75%
Interest
488.00
427.00
14.29%
Exceptional Items
-1,910.00
-1,380.00
-38.41%
Consolidate Net Profit
51,401.00
51,054.00
0.68%
Operating Profit Margin (Excl OI)
299.00%
297.60%
0.14%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 1.68% vs -1.85% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 0.68% vs 0.62% in Mar 2025

Annual Results Snapshot (Consolidated) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
866,032.00
762,610.00
13.56%
Operating Profit (PBDIT) excl Other Income
392,211.00
343,856.00
14.06%
Interest
1,326.00
1,079.00
22.89%
Exceptional Items
-4,733.00
-7,412.00
36.14%
Consolidate Net Profit
201,750.00
182,566.00
10.51%
Operating Profit Margin (Excl OI)
396.80%
389.00%
0.78%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 13.56% vs 5.39% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 10.51% vs 8.16% in Mar 2024

stock-summaryCompany CV
About HOYA Corp. stock-summary
stock-summary
HOYA Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available